Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

Recruiting Observational Study
Lung Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
75,000 (estimated)
Sponsor
UNICANCER · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospitals).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria : * Adult (over 18) * Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site Exclusion criteria \- None
Contacts

Lise Bosquet, MsC

0033668642660

l-bosquet@unicancer.fr

CONTACT

Mathieu Robain, MD, PhD

0033144235553

m-robain@unicancer.fr

CONTACT